ACCURAY INCORPORATED

ARAY ·Healthcare, Medical Devices, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2018 FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Revenue $404.9M $383.4M $398.8M $379.8M $369.4M $316.0M $409.2M $222.3M
Cost of Revenue $243.2M $242.1M $240.1M $234.4M $226.6M $218.3M $272.0M $115.0M
Gross Profit $161.7M $141.3M $158.7M $145.4M $142.8M $97.6M $137.3M $107.2M
Gross Margin 39.9% 36.9% 39.8% 38.3% 38.7% 30.9% 33.5% 48.2%
Operating Expenses
Research & Development $57.3M $49.9M $56.7M $55.8M $53.7M $66.2M $81.3M $41.3M
SG&A Expense $48.1M $43.8M $50.1M $46.4M $45.3M $57.7M $57.7M $56.6M
Operating Income $-3.8M $-9.8M $-4.9M $-19.2M $-18.1M $-80.7M $-56.2M $-27.8M
Operating Margin -0.9% -2.6% -1.2% -5.0% -4.9% -25.5% -13.7% -12.5%
Interest Expense $15.0M $17.3M $17.5M $16.5M $14.3M $10.4M $7.4M
Pretax Income $-23.0M $-28.5M $-23.2M $-37.8M $-32.4M $-93.8M $-68.8M $-25.5M
Income Tax Expense $878.0K $1.0M $2.3M $2.4M $3.1M $3.6M $2.6M $1.1M
Net Income $-23.9M $-29.6M $-25.5M $-40.2M $-35.4M $-116.5M $-78.5M $-27.1M
Net Margin -5.9% -7.7% -6.4% -10.6% -9.6% -36.9% -19.2% -12.2%
EPS (Basic) $-0.28 $-0.36 $-0.32 $-0.51 $-0.47 $-1.41 $-1.02 $-0.44
EPS (Diluted) $-0.28 $-0.36 $-0.32 $-0.51 $-0.47 $-1.41 $-1.02 $-0.44
Shares Outstanding (Basic) 84.9M 83.7M 81.6M 79.7M 77.3M 73.3M 70.9M 60.1M
Shares Outstanding (Diluted) 84.9M 83.7M 81.6M 79.7M 77.3M 73.3M 70.9M 60.1M
Dividends Per Share
← Newer Page 2 of 3 Older →